Australia markets closed

ZIVO Bioscience, Inc. (9R8.SG)

Stuttgart - Stuttgart Delayed price. Currency in EUR
Add to watchlist
3.21000.0000 (0.00%)
At close: 07:12PM CET
Show:
Annual

Income statement

Currency in USD. All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Total revenue
0
27.65
0
0
20
Cost of revenue
16.04
16.04
0
-
-
Gross profit
11.61
11.61
0
-
-
Operating expenses
Research development
2,430
1,377
2,240
1,951
3,755
Selling general and administrative
7,336
5,898
6,492
6,695
4,821
Total operating expenses
9,766
7,275
8,732
8,645
8,576
Operating income or loss
-9,766
-7,263
-8,732
-8,645
-8,556
Interest expense
11.713
514.172
13.319
233.282
550.054
Total other income/expenses net
-
-
-
122.52
-
Income before tax
-9,777
-7,777
-8,745
-8,756
-9,106
Income from continuing operations
-9,777
-7,777
-8,745
-8,756
-9,106
Net income
-9,777
-7,777
-8,745
-8,756
-9,106
Net income available to common shareholders
-9,777
-7,777
-8,745
-8,756
-9,106
Basic EPS
-5.52
-
-5.58
-6.90
-10.58
Diluted EPS
-5.52
-
-5.58
-6.90
-10.58
Basic average shares
1,570
-
1,570
1,272
860.49
Diluted average shares
1,570
-
1,570
1,272
860.49